| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,830,000 |
| Market
Cap: |
3.85(B) |
| Last
Volume: |
282,124 |
Avg
Vol: |
696,159 |
| 52
Week Range: |
$36.45 - $67.51 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 443 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
12,975 |
| Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
| Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
5 |
5 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Casal Frank |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
5,789 |
|
- |
|
| Puhy Dorothy E |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
3,604 |
|
- |
|
| Nova Tina Susan |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
3,604 |
|
- |
|
| Davis Robyn C |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
27,122 |
|
- |
|
| Palepu Krishna G. |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
105,393 |
|
- |
|
| Martin Joseph R |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,268 |
92,957 |
|
- |
|
| Rosenblatt Michael |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
10,577 |
|
- |
|
| Zane Ellen M |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
59,900 |
|
- |
|
| Mclaughlin Erica |
Director |
– • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
10,353 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2023-01-31 |
4 |
A |
$46.92 |
$13,091 |
D/D |
279 |
117,458 |
|
- |
|
| Sriram Vandana |
SVP Finance & Corp. Controller |
• – – |
2023-01-31 |
4 |
A |
$46.92 |
$17,313 |
D/D |
369 |
6,356 |
|
- |
|
| Zhou Ginger |
SVP and General Manager, Genom |
• – – |
2023-01-31 |
4 |
A |
$46.92 |
$15,155 |
D/D |
323 |
8,814 |
|
- |
|
| Vacha Robin |
SVP, GM Life Science Products |
• – – |
2023-01-31 |
4 |
A |
$46.92 |
$12,434 |
D/D |
265 |
32,499 |
|
- |
|
| Crowley Kimberly |
SVP, Chief HR Officer |
• – – |
2023-01-31 |
4 |
A |
$46.92 |
$8,305 |
D/D |
177 |
7,399 |
|
- |
|
| Sriram Vandana |
VP, Finance & Corp. Controller |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,519 |
5,987 |
|
- |
|
| Coyne Mitchell |
SVP and GM, Life Sciences Proj |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,889 |
1,889 |
|
- |
|
| Gray David C |
Chief Strategy & New Business |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,148 |
92,219 |
|
- |
|
| Crowley Kimberly |
SVP, Chief HR Officer |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,519 |
7,222 |
|
- |
|
| Robertson Lindon G |
EVP & Chief Financial Officer |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,296 |
117,179 |
|
- |
|
| Schwartz Stephen S |
CEO |
• • – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,886 |
420,527 |
|
- |
|
| Vacha Robin |
SVP, GM Life Science Products |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,778 |
32,234 |
|
- |
|
| Joseph Jason |
SVP, General Counsel, Secy. |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,778 |
99,780 |
|
- |
|
| Zhou Ginger |
SVP and General Manager, Genom |
• – – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,889 |
8,491 |
|
- |
|
| Zhou Ginger |
SVP and General Manager, Genom |
• – – |
2022-11-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,045 |
|
-25% |
|
| Gray David C |
Chief Strategy & New Business |
• – – |
2022-11-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,235) |
89,071 |
|
- |
|
1054 Records found
|
|
Page 3 of 43 |
|
|
0.68 (1.32%) 
